Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data

2018 ◽  
Vol 132 ◽  
pp. 138-144 ◽  
Author(s):  
C. van Marcke ◽  
A. Collard ◽  
M. Vikkula ◽  
F.P. Duhoux
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
High Risk ◽  
Panel Data ◽  
Meta Analysis ◽  
Gene Panel ◽  
Variants Of Unknown Significance ◽  
Pathogenic Variants ◽  
Unknown Significance

Prognostic Value of Differentially Expressed LncRNAs in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

2020 ◽  
Vol 30 (5) ◽  
pp. 447-456
Author(s):  
Dilihumaer Tuluhong ◽  
Wangmu Dunzhu ◽  
Jingjie Wang ◽  
Tao Chen ◽  
Hanjun Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Triple Negative Breast Cancer ◽  
Prognostic Value ◽  
Triple Negative ◽  
Meta Analysis ◽  
Differentially Expressed

Copper Concentrations in Breast Cancer: A Systematic Review and Meta-Analysis

2020 ◽  
Vol 27 (37) ◽  
pp. 6373-6383 ◽  
Author(s):  
Leila Jouybari ◽  
Faezeh Kiani ◽  
Farhad Islami ◽  
Akram Sanagoo ◽  
Fatemeh Sayehmiri ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Breast Tissue ◽  
Reference Lists ◽  
Meta Analysis ◽  
Cancer Risks ◽  
Hair Samples ◽  
Significant Difference ◽  
Mean Differences ◽  
Very High

: Breast cancer is the most common neoplasm, comprising 16% of all women's cancers worldwide. Research of Copper (Cu) concentrations in various body specimens have suggested an association between Cu levels and breast cancer risks. This systematic review and meta-analysis summarize the results of published studies and examine this association. We searched the databases PubMed, Scopus, Web of Science, and Google Scholar and the reference lists of relevant publications. The Standardized Mean Differences (SMDs) between Cu levels in cancer cases and controls and corresponding Confidence Intervals (CIs), as well as I2 statistics, were calculated to examine heterogeneity. Following the specimens used in the original studies, the Cu concentrations were examined in three subgroups: serum or plasma, breast tissue, and scalp hair. We identified 1711 relevant studies published from 1984 to 2017. There was no statistically significant difference between breast cancer cases and controls for Cu levels assayed in any studied specimen; the SMD (95% CI) was -0.01 (-1.06 - 1.03; P = 0.98) for blood or serum, 0.51 (-0.70 - 1.73; P = 0.41) for breast tissue, and -0.88 (-3.42 - 1.65; P = 0.50) for hair samples. However, the heterogeneity between studies was very high (P < 0.001) in all subgroups. We did not find evidence for publication bias (P = 0.91). The results of this meta-analysis do not support an association between Cu levels and breast cancer. However, due to high heterogeneity in the results of original studies, this conclusion needs to be confirmed by well-designed prospective studies.

scholarly journals Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis

2019 ◽  
Vol 12 (8) ◽  
pp. 815-824 ◽  
Author(s):  
Anne Julienne Genuino ◽  
Usa Chaikledkaew ◽  
Due Ong The ◽  
Thanyanan Reungwetwattana ◽  
Ammarin Thakkinstian
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Early Stage ◽  
Meta Analysis ◽  
Early Stage Breast Cancer ◽  
Her2 Positive ◽  
Adjuvant Trastuzumab

OC.15.1 EUS-GUIDED VS PERCUTANEOUS DRAINAGE FOR ACUTE CHOLECYSTITIS IN HIGH-RISK PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

2019 ◽  
Vol 51 ◽  
pp. e118
Author(s):  
A. Tringali ◽  
M. Cintolo ◽  
E. Stasi ◽  
F. Pugliese ◽  
E. Forti ◽  
...  
Keyword(s):  
Systematic Review ◽  
High Risk ◽  
Acute Cholecystitis ◽  
Percutaneous Drainage ◽  
Meta Analysis ◽  
High Risk Patients ◽  
Risk Patients
Sign in / Sign up

Export Citation Format

Share Document